Cargando…

GNPNAT1 Predicts Poor Prognosis and Cancer Development in Non-Small Cell Lung Cancer

BACKGROUND: Glucosamine-phosphate N-acetyltransferase 1 (GNPNAT1) is a key enzyme in the biosynthetic pathway of uridine diphosphate-N-acetylglucosamine and is upregulated in multiple malignancies. However, its function in cancer biology remains unclear. METHODS: Using TCGA dataset, this study analy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yong, Li, Na, Ren, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375989/ https://www.ncbi.nlm.nih.gov/pubmed/35975106 http://dx.doi.org/10.2147/CMAR.S367857

Ejemplares similares

Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Liu, Wenting, et al.
Publicado: (2021)

Independent Prognostic Potential of GNPNAT1 in Lung Adenocarcinoma
por: Zheng, Xiangyu, et al.
Publicado: (2020)

GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2023)

GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer
por: Yuan, Renjie, et al.
Publicado: (2023)

Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor Prognosis
por: Wang, Kaiyuan, et al.
Publicado: (2019)

Overexpression of periostin predicts poor prognosis in non-small cell lung cancer
por: HONG, LING-ZHI, et al.
Publicado: (2013)

NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
por: Li, Zhenling, et al.
Publicado: (2015)

High expression of Stabilin-2 predicts poor prognosis in non-small-cell lung cancer
por: Yong, Juanjuan, et al.
Publicado: (2021)

Involvement of CHP2 in the Development of Non–Small Cell Lung Cancer and Patients’ Poor Prognosis
por: Xu, Liqin, et al.
Publicado: (2020)

MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer
por: Sun, Lichao, et al.
Publicado: (2019)

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer()
por: Zhu, Jinhong, et al.
Publicado: (2016)

Correlation of SIDT1 with Poor Prognosis and Immune Infiltration in Patients with Non-Small Cell Lung Cancer
por: Tian, Yubin, et al.
Publicado: (2022)

Expression of Cripto‐1 predicts poor prognosis in stage I non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2020)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

BCAR1 Protein Plays Important Roles in Carcinogenesis and Predicts Poor Prognosis in Non-Small-Cell Lung Cancer
por: Huang, Wei, et al.
Publicado: (2012)

Flattened microvessel independently predicts poor prognosis of patients with non-small cell lung cancer
por: Fang, Luo, et al.
Publicado: (2017)

Increased Expression of TAP Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer
por: Cheng, Yuanjun, et al.
Publicado: (2020)

High CEP55 expression is associated with poor prognosis in non-small-cell lung cancer
por: Jiang, Chao, et al.
Publicado: (2018)

High CD133 Expression in the Nucleus and Cytoplasm Predicts Poor Prognosis in Non-Small Cell Lung Cancer
por: Huang, Minjie, et al.
Publicado: (2015)

The novel lncRNA PTTG3P is downregulated and predicts poor prognosis in non-small cell lung cancer
por: Huang, Hai-Tao, et al.
Publicado: (2020)

Correction: BCAR1 Protein Plays Important Roles in Carcinogenesis and Predicts Poor Prognosis in Non-Small-Cell Lung Cancer
por: Huang, Wei, et al.
Publicado: (2012)

Activation of Janus kinase 1 confers poor prognosis in patients with non-small cell lung cancer
por: Liu, Dan, et al.
Publicado: (2017)

Enhanced expression of FGF19 predicts poor prognosis in patients with non-small cell lung cancer
por: Chen, Jia, et al.
Publicado: (2021)

Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer
por: Liu, Fayong, et al.
Publicado: (2021)

Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer
por: Zhou, Yujuan, et al.
Publicado: (2016)

PD-L1 Predicts Poor Prognosis in Surgically Resected Limited Stage Small-Cell Lung Cancer
por: Fu, Xiao, et al.
Publicado: (2020)

Downregulation of ARID1A is correlated with poor prognosis in non-small cell lung cancer
por: Wang, Tao, et al.
Publicado: (2020)

Decreased expression of speckle-type POZ protein for the prediction of poor prognosis in patients with non-small cell lung cancer
por: Li, Jing-Jing, et al.
Publicado: (2017)

Long Distance From Microvessel to Cancer Cell Predicts Poor Prognosis in Non-Small Cell Lung Cancer Patients
por: Ding, Haiying, et al.
Publicado: (2021)

MicroRNA-1301-3p promotes the progression of non-small cell lung cancer by targeting Thy-1 and predicts poor prognosis of patients
por: Xu, Ling, et al.
Publicado: (2021)

Aurora-A contributes to cisplatin resistance and lymphatic metastasis in non-small cell lung cancer and predicts poor prognosis
por: Xu, Jie, et al.
Publicado: (2014)

High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer
por: Lu, Jianjun, et al.
Publicado: (2016)

Expression of TLR4 in Non-Small Cell Lung Cancer Is Associated with PD-L1 and Poor Prognosis in Patients Receiving Pulmonectomy
por: Wang, Kaiyuan, et al.
Publicado: (2017)

Elevated expression of mcl-1 inhibits apoptosis and predicts poor prognosis in patients with surgically resected non-small cell lung cancer
por: Wen, Qiuyuan, et al.
Publicado: (2019)

Long non-coding RNA LSAMP-1 is down-regulated in non-small cell lung cancer and predicts a poor prognosis
por: Gong, Wei, et al.
Publicado: (2022)

Overexpression of Muscarinic Receptor 3 Promotes Metastasis and Predicts Poor Prognosis in Non–Small-Cell Lung Cancer
por: Lin, Gengpeng, et al.
Publicado: (2014)

SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway
por: Huang, Shanshan, et al.
Publicado: (2022)

MARCH8 is associated with poor prognosis in non-small cell lung cancers patients
por: Fan, Jiye, et al.
Publicado: (2017)

Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer
por: Ma, Weijie, et al.
Publicado: (2023)

Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer
por: Keum, J S, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_4kg6ubgdku50mdtun1idefnmm7